• 1
    Harris NL. Lymphoid proliferations of the salivary glands. Am J Clin Pathol 1999; 111 Suppl 1: S94103.
  • 2
    Jaffe ES. Lymphoid lesions of the head and neck: a model of lymphocyte homing and lymphomagenesis. Mod Pathol 2002; 15: 25563.
  • 3
    Anaya JM, McGuff HS, Banks PM, Talal N. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome. Semin Arthritis Rheum 1996; 25: 33746.
  • 4
    Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM, and the Members of the European Concerted Action on Sjögren's syndrome. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's syndrome. Arthritis Rheum 1999; 42: 176572.
  • 5
    Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998; 1102: 93846.
  • 6
    Bahler DW, Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren's syndrome) begin as nonmalignant antigen-selected expansion. Blood 1998; 91: 186472.
  • 7
    Bahler DW, Miklos JA, Swerdlow SH. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue type lymphomas. Blood 1997; 89: 333544.
  • 8
    Miklos JA, Swerdlow SH, Bahler DW. Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin VH genes show frequent use of VH1-69 with distinctive CDR3 features. Blood 2000; 95: 387884.
  • 9
    Gasparotto D, de Vita S, de Re V, Marzotto A, de Marchi G, Scott CA, et al. Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering. Arthritis Rheum 2003; 48: 31816.
  • 10
    Martin T, Weber JC, Levallois H, Labouret N, Soley A, Koenig S, et al. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum 2000; 43: 90816.
  • 11
    Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in clonal expansion. Leukemia 1996; 10: 11907.
  • 12
    Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 64453.
  • 13
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 5548.
  • 14
    Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981; 75: 81621.
  • 15
    Brinckmann R, Kaufmann O, Reinartz B, Dietel M. Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B cell lymphomas. J Pathol 2000; 190: 5560.
  • 16
    Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 21929.
  • 17
    Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 1995; 155: 190202.
  • 18
    Heimbacher C, Hansen A, Pruss A, Jacobi A, Reiter K, Lipsky P, et al. Immunoglobulin Vk light chain analysis in patients with Sjögren's syndrome. Arthritis Rheum 2001; 44: 62637.
  • 19
    Kaschner S, Hansen A, Jacobi A, Reiter K, Monson NL, Odendahl M, et al. Immunoglobulin Vκ light chain gene usage in patients with Sjögren's syndrome. Arthritis Rheum 2001; 44: 262032.
  • 20
    Tapinos NI, Polihronis M, Moutsopoulos HM. Lymphoma development in Sjögren's syndrome: novel p53 mutations. Arthritis Rheum 1999; 42: 146672.
  • 21
    Takacs I, Zeher M, Urban L, Szegedi G, Semsei I. Diagnostic value of the detection of t(14;18) chromosome translocation in malignant haematological and immunopathological diseases using polymerase chain reaction. Acta Med Okayama 2000; 54: 18592.
  • 22
    Ferry JA, Harris NL. Atlas of lymphoid hyperplasia and lymphoma. 1st ed. Philadelphia: WB Saunders Company; 1997.
  • 23
    Carbone A, Gloghini A, Ferlito A. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type. Ann Otol Rhinol Laryngol 2000; 109: 11705.
  • 24
    Isaacson PG, Wotherspoon AC, Diss T, Pan LX. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol 1991; 15: 81928.
  • 25
    Lamb P, Crawford L. Characterization of the human p53 gene. Mol Cell Biol 1986; 6: 137985.
  • 26
    Villuendas R, Pezella F, Gatter K, Algara P, Sanchez-Beato M, Martinez P, et al. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2−, p21− immunophenotype associated with missense p53 mutations. J Pathol 1997; 181: 5161.
  • 27
    Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101: 122035.
  • 28
    Chang B, Casali P. The CDR1 sequences of a major proportion of human germline IgVH genes are inherently susceptible to amino acid replacement. Immunol Today 1994; 15: 36773.
  • 29
    Hansen A, Jacobi A, Pruss A, Kaufmann O, Scholze J, Lipsky P, et al. Comparison of immunoglobulin heavy chain rearrangements between peripheral and glandular B cells in a patient with primary Sjögren's syndrome. Scand J Immunol 2003; 57: 4709.
  • 30
    Jacobi AM, Hansen A, Kaufmann O, Burmester GR, Lipsky PE, Dorner T. Analysis of immunoglobulin light chain rearrangements in the salivary glands and blood of a patient with Sjögren's syndrome. Arthritis Res 2002; 4: R4.Epub 2002 Jun 11.
  • 31
    Deacon EM, Matthews JB, Potts AJ, Hamburger J, Mageed A, Jefferis R. Expression of rheumatoid factor associated cross reactive idiotypes by glandular B cells in Sjögren's syndrome. Clin Exp Immunol 1991; 83: 2805.
  • 32
    Kipps TJ, Tomhave E, Chen PP, Fox RI. Molecular characterization of a major autoantibody-associated cross-reactive idiotype in Sjögren's syndrome. J Immunol 1989; 142: 42618.
  • 33
    Borretzen M, Randen I, Natvig JB, Thompson KM. Structural restriction in the heavy chain CDR3 of human rheumatoid factors. J Immunol 1995; 155: 36307.
  • 34
    Brezinschek HP, Brezinschek RI, Dorner T, Lipsky PE. Similar characteristics of the CDR3 of VH1-69/DP-10 rearrangements in normal human peripheral blood and chronic leukaemia B cells. Br J Haematol 1998; 102: 51621.
  • 35
    Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 151525.
  • 36
    Bertoni F, Gisi M, Roggero E, Conconi A, Mingrone W, Cavalli F, et al. Molecular detection of circulating neoplastic cells in patients with clinically localised gastric and non-gastric mucosa-associated lymphoid tissue lymphoma. Dig Liver Dis 2000; 32: 18891.
  • 37
    Suefuji H, Ohshima K, Karube K, Kawano R, Nabeshima K, Suzumiya J, et al. CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone. Int J Cancer 2005; 114: 896901.
  • 38
    Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR, et al, and the Non-Hodgkin's Lymphoma Classification Project. Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. J Clin Oncol 1999; 17: 248692.
  • 39
    Shiokawa S, Miyazaki Y, Nakamura M, Nakayama T, Ohshima K, Suehiro Y, et al. Expansion of identical B-cell clones in the bilateral parotid glands and their circulation in the peripheral blood in a patient with Sjögren's syndrome. Mod Rheumatol 2000; 10: 5861.
  • 40
    De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avelline C, Dolcetti R, et al. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis Rheum 1997; 40: 31831.
  • 41
    Elagib KE, Borretzen M, Thompson KM, Natvig JB. Light chain variable (VL) sequences of rheumatoid factors (RF) in patients with primary Sjögren's syndrome (pSS): moderate contribution of somatic hypermutation. Scand J Immunol 1999; 50: 4928.
  • 42
    Kuppers R, Zhao M, Hansmann ML, Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993; 12: 495567.
  • 43
    Friedman DF, Cho EA, Goldman J, Carmack CE, Besa EC, Hardy RR, et al. The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma. J Exp Med 1991; 174: 52537.
  • 44
    Streubel B, Simonitsch-Klupp I, Müllauer L, Lamprecht A, Huber D, Siebert R, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18: 17226.
  • 45
    Aiello A, Du MQ, Diss TC, Peng HZ, Pezzella F, Papini D, et al. Simultaneous phenotypically distinct but clonally identical mucosa-associated lymphoid tissue and follicular lymphoma in a patient with Sjögren's syndrome. Blood 1999; 94: 224751.
  • 46
    Du MQ, Diss TC, Dogan A, Ye HT, Aiello A, Wotherspoon AC, et al. Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa. J Pathol 2000; 192: 48893.
  • 47
    Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 2005; 11: 334952.
  • 48
    Kabat EA, Wu TT, Perry HM, Gottesmann KS, Foeller C. Sequences of proteins of immunological interest. 5th ed. Vol. I. Bethesda: National Institutes of Health; 1991.